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Nationwide, opioid misuse among pregnant women has risen four-fold from 1999 to
2014, with commensurate increase in neonates hospitalized for neonatal abstinence
syndrome (NAS). NAS occurs when a fetus exposed to opioids in utero goes into rapid
withdrawal after birth. NAS treatment via continued post-natal opioid exposure has been
suggested to worsen neurodevelopmental outcomes. We developed a novel model to
characterize the impact of in utero and prolonged post-natal oxycodone (Oxy) exposure
on early behavior and development. Via subcutaneous pump implanted before breeding,
C57BL/6J dams were infused with Oxy at 10 mg/kg/day from conception through
pup-weaning. At birth, in utero oxy-exposed pups were either cross-fostered (paired
with non-Oxy exposed dams) to model opioid abstinence (in utero Oxy) or reared by
their biological dams still receiving Oxy to model continued post-natal opioid exposure
(prolonged Oxy). Offspring from vehicle-exposed dams served as cross-fostered (in
utero Veh) or biologically reared (prolonged Veh) controls. In utero Oxy exposure resulted
in sex-dependent weight reductions and altered spectrotemporal features of isolationinduced ultrasonic vocalization (USV). Meanwhile, prolonged Oxy pups exhibited
reduced weight and sex-differential delays in righting reflex. Specifically, prolonged
Oxy female offspring exhibited increased latency to righting. Prolonged Oxy pups also
showed decreases in number of USV calls and changes to spectrotemporal USV
features. Overall, ontogenetic Oxy exposure was associated with impaired attainment
of gross and sensorimotor milestones, as well as alterations in communication and
affective behaviors, indicating a need for therapeutic interventions. The model developed
here will enable studies of withdrawal physiology and opioid-mediated mechanisms
underlying these neurodevelopmental deficits.
Keywords: opioid, behavior, in utero, post-natal, oxycodone, neonatal abstinence syndrome
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effects on developmental outcomes (Slamberová et al., 2005;
Niu et al., 2009). Opioids exert their pharmacologic effects
by activating the endogenous opioid system. While opioids
are prescribed for their analgesic effects, acute activation of
the µ-opioid receptor (MOR) by these medications has also
been associated with feelings of euphoria, award reinforcement,
and increased socio-emotional processing, which are linked
to the drugs’ potential for misuse (Vanderschuren et al.,
1995). Despite the rising incidence of Oxy misuse, there is
a paucity of literature evaluating the effects of Oxy, a µand κ-agonist, on early developmental behaviors. κ-agonists
are of particular interest because over-activation of κ-opioid
receptors (KOR) by dynorphin upregulation has been implicated
in withdrawal physiology and depressed mood in humans, along
with decreased social play in juvenile rodents (Vanderschuren
et al., 1995; Li et al., 2016). In addition, most rodent opioid
exposure models begin exposure mid-pregnancy, which may
explain inconsistently documented or absent developmental
changes (Richardson et al., 2006). To address the above
concerns, we are adopting an ontogenetic model in which
opioid exposure spans preconception through early offspring
development. This new model also enables us to better
understand the ontogenetic impact of short- and long-term
opioid exposure on early development in the absence of
confounding factors present in clinical observational studies.
Specifically, we evaluated the effects of in utero Oxy exposure
on early developmental and behavioral outcomes in male and
female offspring of C57BL/6J mouse dams. We implemented
a cross-fostering approach that allows us to compare the
neurodevelopmental impact of continued post-natal opioid
exposure (prolonged Oxy) to the impact of exposure only until
birth (in utero Oxy) by pairing opioid exposed pups with
non-oxy exposed dams.
Overall, we observed differences in the spectrotemporal
features of affective vocalizations and sex-based differences in
weight gain trajectories in offspring exposed to in utero Oxy.
Continued post-natal Oxy exposure (prolonged Oxy) further
impacted weight, communicative behavior, and sensorimotor
reflexes. Our findings suggest that pups with continued postnatal opioid exposure showed worse overall developmental
outcomes compared to pups following opioid cessation at
birth, which may have implications regarding the safety
of continued opioid treatment as mitigation for clinical
NAS symptomology.

INTRODUCTION
In the past two decades, illicit drug use and prescription opioid
use in the United States have risen to epidemic proportions, with
the United States Department of Health declaring a public health
emergency in 2017. The United States Department of Health
states that 46,802 people died from opioid overdose in 2018 and
an estimated 2 million people have an opioid use disorder (ASPA,
2017). The public health crisis is largely driven by increased
misuse of the prescription opioids hydrocodone, oxycodone
(Oxy), and methadone (Kenan et al., 2012; Haight, 2018).
As a result of the opioid epidemic, the national prevalence
of opioid use disorder among pregnant women has more
than quadrupled, from 1.5 to 6.5 per 1,000 deliveries, from
1999 through 2014 (Haight, 2018). Consequently, there
has been a significant increase in the number of neonates
hospitalized for neonatal abstinence syndrome (NAS), a
constellation of withdrawal symptoms affecting the nervous
system, gastrointestinal tract, and respiratory system following in
utero exposure to opioids (Wiles et al., 2014). Currently, medical
management of NAS involves keeping the infant swaddled in
a low-stimulation environment with promotion of maternalinfant bonding (Wiles et al., 2014). In cases of moderate-severe
NAS, neonatal withdrawal is managed by opioid replacement
therapy to alleviate withdrawal symptomatology (Wiles et al.,
2014). Overall, clinical studies have not addressed whether
long-term neurobehavioral outcomes are improved by managing
withdrawal or whether continued post-natal exposure to opioids
and adjunct agents used for withdrawal management worsen
long-term outcomes (Hudak et al., 2012).
Epidemiological evidence suggests that in utero opioid
exposure is associated with lower birth weight and adverse
neurodevelopmental outcomes in childhood, including
cognitive deficits, attention deficit hyperactivity disorder
(ADHD), aggression, impaired language development, and
decreased social maturity (Hunt et al., 2008; Azuine et al.,
2019; Conradt et al., 2019). However, large epidemiological
studies evaluating long-term behavioral outcomes of children
exposed to in utero opioids have been difficult to perform due
to confounding environmental variables including genetic and
epigenetic factors, quality of caregiving, continued parental
substance abuse with its impact on the maternal-infant dyad,
and other socioeconomic variables which can significantly
affect neurodevelopmental outcomes (Lutz and Kieffer, 2013).
Consequently, the development of ontogenetic rodent models
of opioid exposure is necessary to enable investigation of the
biological mechanisms mediating deficits as well as testing
alternative treatment avenues for post-natal withdrawal.
To date, there have been a limited number of rodent studies
evaluating early life developmental milestones following in utero
opioid exposure. Current literature on early developmental
effects of in utero opioid exposure in pre-clinical models
demonstrates decreased birth weight following methadone and
buprenorphine exposure (Kunko et al., 1996; Hung et al.,
2013; Chiang et al., 2015). Increased latency to right has
been observed following in utero morphine exposure and
is suggestive of different classes of opioids having variable
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MATERIALS AND METHODS
Animals
Animal Ethics, Selection, and Welfare
All procedures using mice were approved by the Washington
University Institutional Care and Use Committee and conducted
in accordance with the approved Animal Studies Protocol.
C57BL/6J mice (Jackson Laboratory, stock #: 000664) were
housed in individually ventilated translucent plastic cages (IVC)
measuring 36.2 × 17.1 × 13 cm (Allentown) with corncob
bedding and ad libitum access to standard lab diet and

2

February 2021 | Volume 15 | Article 615798

Minakova et al.

Oxycodone Exposure Affects Early Life Neurodevelopment

them to the nest of a lactating foster dam with two of her own
pups of the same approximate age (Figure 1B; Lohmiller and
Swing, 2006). The remaining litters were reared by the biological
dam and exposed to post-natal vehicle (prolonged Veh) or Oxy
(prolonged Oxy) through lactation (Figures 1A,B). To control
for litter effects, each group included multiple, independent litters
(Table 1). All mice were weaned at P21 and group-housed by
sex with random assignment for drug/dam. A subset of the
in utero Oxy mice required saline injections at P23-P25 due
to skin tenting, hunched posture, and significant weight loss
concerning for dehydration. Following saline injections, recovery
was noted in two of the three affected mice with one associated
mortality. Experimenters were all female and blinded to group
designations during testing.

TABLE 1 | Litter and group size, including number of pups at the level of litter,
group, and experiment.
Litter ID

Group

No. of pups

1

Prolonged Oxy

5

2

Prolonged Oxy

4

3

Prolonged Oxy

3

4

Prolonged Oxy

6

5

Prolonged Oxy

Total:

6
24

6

In utero Oxy

5

7

In utero Oxy

6

8

In utero Oxy

6

9

In utero Oxy

6

10

In utero Oxy

Total:

6
29

Drug Dosage
The dosage of Oxy (Sigma-Aldrich, Saint Louis, MO,
United States; Lot#: SLBX4974) administration was guided
by previous literature with concentrations ranging from 0.5 to
33 mg/kg/day (Enga et al., 2016; Sithisarn et al., 2017; Zanni
et al., 2020). Based on this dosage range, we generated our
own dosage curve through continuous Oxy administration to
pregnant dams at 5, 10, or 15 mg/kg/day using the subcutaneous
Alzet 2006 model pump (Durect Corporation, Cupertino,
CA, United States; Lot #: 10376-17). We chose the dose of
10 mg/kg/day administered at 0.15 ul/h to pregnant dams
as increased concentrations at 15 mg/kg/day resulted in
lower litter success rate (vehicle, 5 and 10 mg/kg/d: 100%
success rate; 15 mg/kg/d: 80% success rate). We chose to
administer a consistent dose of opioids to the dam throughout
pregnancy and lactation to model the current management
of pregnant mothers with opioid use disorder. Women with
opioid use disorder are now encouraged to enroll in opioid
medication-assisted treatment programs with the goal of
attaining a steady-state drug level. Maintaining a consistent
level of opioid administration during pregnancy in mothers
with opioid use disorder limits adverse maternal and fetal
consequences associated with fluctuations related to higher
opioid concentrations. Increases in opioid dosage can result
in maternal respiratory depression and lethal overdose and
may decrease fetal heart rate and variability (Krans et al., 2015;
Rosenthal and Baxter, 2019).

11

Prolonged Veh

6

12

Prolonged Veh

6

13

Prolonged Veh

6

14

Prolonged Veh

6

15

Prolonged Veh

Total:

6
30

16

In utero Veh

17

In utero Veh

5
6

18

In utero Veh

3

19

In utero Veh

6

20

In utero Veh

5

21

In utero Veh

Total:

3
28

Total pups:

111

water. Animals were kept at 12/12 h light/dark cycle, and
room temperature (20–23◦ C) and relative humidity (50%) were
controlled automatically.
Adult male and female mice were used for breeding cohorts
as described below. Sample sizes were determined by power
analyses (f = 0.40, α = 0.05, 1-β = 0.80). A total of 24 dams were
housed in pairs and randomly selected to receive either the Oxy
or Vehicle (Veh) treatment infusion. In addition, another set of
pair-housed, drug-naïve dams served as foster dams. The total
sample size was 111 pups (Table 1). Since an inexperienced dam
can exhibit poor maternal behavior with her first litter, all females
were first bred to an age-matched male at post-natal day (P) 60.
Following weaning of the first litter, treatment dams underwent
surgical subcutaneous pump placement at P95 followed by a 1week recovery period (Figure 1A). Afterward, each female dam
was placed into an individual cage containing a male for breeding.
Foster dams were bred at the same time and remained untreated
throughout pregnancy. Following 20 days of co-habitation, cages
were checked daily for pups. Upon detection, dam and litter
were moved to a new cage, without the male, and culled to 6–
8 pups per litter with equal males and females when possible.
To evaluate the behavioral impact of early opioid cessation in
the developing offspring, half of the litters (in utero Oxy and in
utero Veh) were cross-fostered at this time to drug-naïve dams
by removing the pups from their biological dam and transferring

Frontiers in Behavioral Neuroscience | www.frontiersin.org

Surgery and Drug Delivery System
Female dams were anesthetized at P95 with isoflurane (5%
induction, 2% maintenance, 0.5 l/min) and placed in the
mouse adapter (Stoelting, Wood Dale, IL, United States). Body
temperature was maintained at 37◦ C using a heating pad. The
dorsum of the back was shaved and a ∼1 cm horizontal incision
was made below the scapulae with subsequent formation of
a subcutaneous pocket. The Alzet pump was implanted and
continuously infused with either Oxy or sterile 0.9% NaCl (Veh)
over a period of 60 days. The pump duration allowed for adequate
post-surgical recovery time, breeding, and administration of
treatment through weaning of offspring at P21. In addition, the
use of a subcutaneous pump limited unwanted maternal stress
that can occur with daily injections.
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RIGHTING
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WEANING

WEIGHT

P122
P0

In utero

USV

{

A
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P5

P7

P9

P11

P14

P143
P21

P30

Prolonged Maternal Treament

REARED BY FOSTER NON-EXPOSED DAMS

B

In utero Oxy

P21

BIRTH
& FOSTERING

DEVELOPMENTAL
ASSESSMENT

Pup
P0

OXYCODONE Pup
EXPOSED
E0
DAMS (E0-P21)
(n = 12)

Prolonged Oxy

REARED BY OXY-EXPOSED DAMS

P21

REARED BY FOSTER NON-EXPOSED DAMS

In utero Veh

P21

BIRTH
& FOSTERING

DEVELOPMENTAL
ASSESSMENT

VEHICLE

EXPOSED
DAMS (E0-P21)
(n = 12)

Pup
E0

Pup
P0

Prolonged Veh

REARED BY VEH-EXPOSED DAMS

P21
FIGURE 1 | Ontogenetic model of prolonged and limited maternal Oxy exposure. (A) Schematic of the paradigm for maternal Oxy exposure, including duration of in
utero and prolonged maternal treatment, dam ages at experimental manipulations in yellow, and pup age for behavioral tests in purple. (B) Outline of the four
different experimental groups, including Oxy or Veh exposure, and rearing dam exposure status.

the start of testing. We maintained an average pup surface
body temperature of 34◦ C prior to placement into the USV
recording chamber, as low pup body temperature increases USV
production (Branchi et al., 2001). The surface body temperature
of all pups was assessed via a non-contact HDE Infrared
Thermometer prior to placement into the recording chamber,
and no differences in body surface temperature were observed
between groups. The recording chamber was maintained at room
temperature (22–23◦ C). For recording, pups were individually
removed from the home cage and placed into an empty
standard mouse cage (28.5 × 17.5 × 12 cm) inside a soundattenuating chamber (Med Associates). USVs were recorded
via an Avisoft UltraSoundGate CM16 microphone placed 5 cm
away from the top of the cage, Avisoft UltraSoundGate 116H
amplifier, and Avisoft Recorder software (gain = 3 dB, 16 bits,
sampling rate = 250 kHz). Pups were recorded for 3 min,

Behavioral Testing
Maternal Isolation-Induced Ultrasonic Vocalization
Recording
Neonates with NAS often exhibit excessively high-pitched
crying, irritability, and prolonged periods of inconsolability
(Anbalagan and Mendez, 2020). Affective characteristics of
ultrasonic vocalizations (USVs) in rodents are generally thought
to communicate different emotional states, such as aggression
or pain. USV quantity, duration, pitch, frequency, and loudness
(dB) of the calls allow for the assessment of call characteristics
following in utero Oxy exposure (Vivian and Miczek, 1993a,b).
USV recordings were performed on P5, P7, P9, and P11
(Figure 1A). Dams were removed from the home cage and
placed into a clean IVC for the duration of testing. The
home cage with the pups in nest was placed into a warming
box (Harvard Apparatus) set to 34◦ C for 10 min prior to

Frontiers in Behavioral Neuroscience | www.frontiersin.org

4

February 2021 | Volume 15 | Article 615798

Minakova et al.

Oxycodone Exposure Affects Early Life Neurodevelopment

after which they were weighed and returned to home cages.
Frequency sonograms were prepared from USV recordings
in MATLAB [frequency range = 25–120 kHz, Fast Fourier
Transform (FFT) size = 512, overlap = 50%, time resolution
1.024 s, frequency resolution = 488.2 Hz]. Individual calls
and other spectrotemporal features were identified from the
sonograms adapted from validated procedures (Holy and Guo,
2005; Maloney et al., 2018a,b).

TABLE 2 | Test statistics from hierarchical linear models.
Variable

Factor

p-value

Weight (g)

Sex

F (1, 107) = 10.219

p = 0.002

Drug

F (1, 109) = 5.448

p = 0.021

Age

F (9, 901) = 785.001

p = 0.000

Litter Size

F (1,102) = 9.922

p = 0.002

F (67, 685) = 4.232

p = 1.2916E−22

Dam

F (1,24) = 4.630

p = 0.042

Sex × Dam × Drug

F (4,74) = 2.518

p = 0.048

Litter Size

F (1,26) = 9.335

p = 0.005

Dam

F (1,156) = 7.015

p = 0.009

Drug

F (1,151) = 12.000

p = 0.001

Dam × Drug

F (1,159) = 5.223

p = 0.024

Litter Size

F (1, 159) = 3.064

p = 0.082

Pitch range
(Hz)

Drug

F (1,169) = 8.456

p = 0.004

Dam × Drug

F (1,169) = 13.528

p = 0.000315

Age × Dam × Drug × Sex

F (24, 319) = 1.385

p = 0.097

Mean pitch
(Hz)

Drug

F (1,160) = 29.552

p = 1.9953E−7

Dam × Sex

F (1,160) = 5.373

p = 0.022

Drug × Sex

F (1,160) = 5.354

p = 0.022

Sex × Dam × Drug

F (1,160) = 8.365

p = 0.004

Sex × Dam × Drug × Age

F (24, 301) = 1.617

p = 0.036

Sex

F (1, 161) = 3.190

p = 0.076

Dam

F (1,163) = 5.632

p = 0.019

Drug

F (1,171) = 10.327

p = 0.002

Dam × Drug

F (1,172) = 12.399

p = 0.001

Litter Size

F (1,161) = 6.313

p = 0.013

Sex × Dam × Drug × Age
Righting
reflex

Developmental Reflexes and Milestones Assessment
Mice were evaluated for achievement of physical and behavioral
milestones from early development through early juvenile stage.
Weight was measured at 10 time points: P5, P7, P9, P11,
P14, P23, P25, P27, and P30. A visual inspection of normal
physical milestone attainment was performed with evaluation for
detached pinnae at P5 and eye opening at P14. Righting reflex
was assessed at P14 as follows: each mouse was placed prone onto
its abdomen and quickly pronated 180◦ to its back in a smooth
motion. The time for the mouse to right itself with all four paws
positioned underneath the abdomen was recorded (Zanni et al.,
2020). Each mouse underwent three timed trials, which were
averaged for analysis.

Number of
USV calls

Statistical Analyses
SPSS (IBM, v.25) was used for all statistical analyses. Data
were screened for missing values, influential outliers, fit between
distributions and the assumptions of normality and homogeneity
of variance. Variables that violated assumptions of normality
(including number of USV calls, mean pitch, pitch range, and
peak power) were square root-transformed. Data were analyzed
using hierarchical linear models with sex clustered within litters
and age clustered within individual pups. Fixed factors were
dam, drug, sex and, where appropriate, age. Age was also treated
as a random repeated effect and was grand mean-centered for
analysis. Interactions between the fixed factors are reported when
significant. If an interaction effect was significant, p-values were
obtained from the hierarchical linear model for simple main
effects and reported for differences between different levels within
the interaction. If sex had a significant main effect, findings are
shown segregated by sex. As litter size can influence behavior and
litter cannot be separated from drug treatment in this study, all
models included litter size as a covariate. Probability value for
all analyses was p < 0.05. Test statistics and analysis details are
provided in Table 2. The datasets generated for this study are
available upon reasonable request to the corresponding author.

Peak
power (dB)

Showing significant main and interaction effects. Age was grand mean-centered
for analysis, where included. Litter size was included as a covariate.

groups for pinnae detachment at P5 or eye opening by P14. In
our analysis of weight, we found male mice weighed significantly
more than females in all groups at all ages, and therefore, weight
data are segregated by sex (Figures 2C,D) from the full factorial
linear mixed model including sex, drug, and duration as factors.
Prolonged Oxy exposure led to an overall decrease in mean
weight compared to prolonged Veh exposure, which was more
pronounced in male offspring. Prolonged Oxy-exposed male
offspring exhibited significantly reduced weights compared to
prolonged Veh offspring post-weaning at P25, P27, and P30, with
non-significant reductions at P23 (Figure 2E). Female prolonged
Oxy offspring showed significantly reduced weight compared
to prolonged Veh controls at P21, P23, and P25, with nonsignificant reductions at P27 and P30 (Figure 2F). These data
indicate that overall prolonged Oxy exposure reduces weight
across development in male and female offspring, with the effect
on weight gain compounding once potentially compensatory
maternal care is lost after weaning.
We then evaluated the potential effects of early opioid
cessation (in utero Oxy) on weight gain in male and female
offspring and once more found male offspring susceptible to Oxy
effects. In contrast to prolonged exposure, an overall reduction in
weight was not observed with in utero Oxy exposure compared
to in utero Veh exposure. However, in utero Oxy males showed
a precipitous decrease in weight gain trajectory after weaning

RESULTS
Oxycodone Impacted Developmental
Weight Trajectories Differentially by Sex
and Exposure Duration
We examined the effects of Oxy administration on gross and
sensorimotor development in mice from birth throughout the
early juvenile stage (Figures 2A,B). To evaluate general health
and gross development, we assessed the appearance of physical
milestones and weight. No differences were observed between
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FIGURE 2 | Prolonged and in utero Oxy exposure, as well as cross-fostering, decreases weight gain after weaning. (A) Schematic of the treatment paradigm for
maternal Oxy exposure and weight measurements throughout development. (B) Line graph of weight in all offspring (sex, p = 0.002; drug, p = 0.021; age,
p < 0.000; sex × dam × drug × age, p = 1.2916E- 22 ). (C,D) Line graph of weight in (C) male and (D) female offspring. (E,F) Prolonged Oxy exposure, relative to
prolonged Veh exposure, led to significantly lower weights post-weaning in (E) male (P23, p = 0.075; P25, p = 0.027; P27, p = 0.011; P30, p = 0.002) and (F)
female offspring (P21, p = 0.010; P23, p = 0.041; P25, p = 0.022; P27, p = 0.075; P30, p = 0.089). (G,H) In utero Oxy exposure, relative to in utero Veh exposure,
led to significantly lower weights post-weaning in (G) male offspring only (P23, p = 0.042; P25, p = 0.001; P27, p = 0.001; P30, p = 0.000018), with no effects in (H)
female offspring. (I,J) In utero Oxy exposure with cross-fostering, relative to prolonged Oxy exposure, led to decreased weight in adolescence in (I) male pups only
(P5, p = 0.049; P25, p = 0.053; P27, p = 0.026; P30, p = 0.002), with no effects in (J) female offspring. (K,L) In utero Veh exposure with cross-fostering, relative to
prolonged Veh exposure, led to decreased weight post-weaning in (K) male (P27, p = 0.063; P30, p = 0.011) and (L) female offspring (P21, p = 0.057; P23,
p = 0.042; P25, p = 0.033; P27, p = 0.064; P30, p = 0.035). Closed circles depict mean weight, with litter size as a covariate (p = 0.002), while open circles depict
individual weights. Gray vertical line indicates date of weaning.

from the foster dam at P23, P25, P27, and P30 as compared to
in utero Veh controls (Figure 2G). Female in utero Oxy offspring
showed no difference in weight across development compared to
in utero Veh controls (Figure 2H). Clinically, male infants are
more susceptible to NAS (Charles et al., 2017), so the precipitous
decrease in weight gain trajectory in the in utero Oxy male
offspring may be associated with withdrawal symptomatology
unmasked by cessation of care under a foster dam.
We also examined weight trajectories between in utero and
prolonged vehicle-exposed groups. In vehicle-exposed males,
cross-fostering was associated with decreased weights in the in
utero Veh group at P30, with a trend toward decreased weight at
P27, relative to the prolonged Veh group (Figure 2K). Of interest,
cross-fostered female pups (in utero Veh) weighed less compared
to prolonged Veh female pups post-weaning at P23, P25, and P30
(Figure 2L). These findings suggest that cross-fostering alone can
influence post-weaning weight trajectories in a sex-dependent
manner. However, it is noteworthy that the decrease of weight
gain trajectories in the male in utero Oxy group persisted above
and beyond the observed decreased weights in male in utero Veh
controls, indicating in utero Oxy exposure affects weight gain
when controlling for cross-fostering (Figure 2G).
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We have shown so far that Oxy exposure, compared to Veh,
decreased post-weaning weight following both long and short
exposures. We next sought to determine how the duration of
Oxy exposure influences weight by assessing the weight gain
trajectory differences between prolonged and in utero Oxy pups.
Comparisons between the male mice showed in utero Oxy pups
initially weighed more than prolonged Oxy pups at P5. However,
after the in utero Oxy male pups were weaned at P21, their
weights decreased relative to the prolonged Oxy group at P27 and
P30 (Figure 2I). No differences in weight gain between in utero
and prolonged groups were detected in female Oxy-exposed pups
(Figure 2J). Overall, early Oxy cessation was associated with
increased weights at very early post-natal ages, followed by weight
loss in males at weaning.

Prolonged Oxycodone Exposure Altered
Sensorimotor Reflex in Female Offspring
Only
Righting reflex at P14 was examined as an assessment of
sensorimotor milestones, early gross locomotor abilities, and
general strength (Figures 3A,B). In males, no difference in
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FIGURE 3 | Oxy exposure delays maturing of sensorimotor reflexes. (A) Schematic of the treatment paradigm for maternal Oxy exposure and righting reflex
measurement throughout development. (B) Mean latency to right in all offspring (sex × dam × drug × age, p = 0.048; dam, p = 0.042). (C,D) Mean latency to right
in (C) male and (D) female offspring. Prolonged Oxy exposure led to significantly longer latency to right relative to in utero Oxy (p = 0.032) in (C) male pups and
relative to prolonged Veh (p = 0.024) in (D) female pups. Male pups exposed to prolonged Veh also show longer latency to right relative to in utero Veh (p = 0.036).
Mean latencies, with litter size as a covariate (p = 0.005), while open circles depict individual latencies. Error bars represent standard error.

latency to right was noted between the prolonged Oxy or
prolonged Veh groups (Figure 3C). An increased latency to right
was demonstrated in prolonged Oxy male pups compared to in
utero Oxy. However, cross-fostering may have a confounding
effect on the righting reflex in male pups, since prolonged
Veh males also exhibited an increased latency to right relative
to in utero Veh males. In females, prolonged Oxy pups
exhibited significantly increased latency to right relative to
prolonged Veh controls (Figure 3D). No significant differences
in the righting reflex were observed in the in utero Oxy or
in utero Veh female offspring. Together, these data indicate
that females, but not males, are susceptible to the effects of
prolonged developmental Oxy exposure on attainment of the
sensorimotor reflex.
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Oxycodone Exposure Disrupts Early
Communicative Behaviors
Language delays have been demonstrated in toddlers with
prenatal opioid exposure (Conradt et al., 2019). Therefore,
we assessed early affective and communicative behaviors by
evaluating maternal isolation-induced USVs. USVs are an
affective and communicative response that elicits maternal search
and retrieval, lactation, and caretaking behaviors (Haack et al.,
2009; Maloney et al., 2018a). As a result, characterization of
quantity and quality of USV calls has been used in the rodent
literature as a model for investigating early communicative
deficits (Enga et al., 2016). Here, we quantified USV production
and spectrotemporal features to examine the influence of Oxy
on early communicative behaviors during the first 2 weeks of
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compared to prolonged Veh females (Figure 5C). However,
female in utero Oxy offspring did exhibit USVs with significantly
lower mean pitch relative to in utero Veh. A similar nonsignificant reduction in mean pitch was observed in USVs
produced by in utero Oxy males relative to in utero Veh
males (Figure 5B). Thus, in utero Oxy exposure was associated
with changes in affective components of communication, the
significance of which warrants further investigation. Since opioid
withdrawal has been associated with high-pitched crying and
increased agitation, we also assessed for alterations in USV peak
power. In utero Oxy exposure resulted in louder USV calls
compared to those produced by prolonged Oxy pups and in utero
Veh controls (Figure 5D). The increased peak power, or loudness,
in in utero Oxy pup calls only may be temporally related to onset
of withdrawal after drug cessation at P0, relative to the prolonged
Oxy pups which are weaned off the drug at P21.
Overall, prolonged Oxy pups demonstrated significant
decreases in number of USVs along with a narrower pitch
frequency range and mean pitch in male pups. In utero Oxy
pups produced a similar number of USVs compared to controls,
yet those calls were louder than controls and prolonged Oxy
calls, and lower in mean pitch when produced by females.
Together, our ontogenetic model of in utero Oxy exposure
demonstrates some alterations in loudness of affective calls,
while the prolonged Oxy exposure further shows alterations in
number and spectrotemporal features of early communicative
and affective behaviors.

life (Figure 4A). Overall, we detected a highly significant effect
of continued Oxy exposure on USV production. Specifically,
prolonged Oxy pups produced significantly fewer USVs relative
to prolonged Veh pups and in utero Oxy pups (Figure 4B), which
persisted from P5 through P11 (Figure 4C), an age at which the
C57Bl/6J strain used here still has a detectable call rate (Rieger
and Dougherty, 2016). While we did not see as substantial of a
peak at P7/P9 as we normally see in these experiments, the effect
of prolonged Oxy was consistent regardless.
Beyond call numbers, spectrotemporal USV features such
as duration, pitch frequency, and power (loudness) inform
of an affective component to USV characteristics (Wöhr and
Schwarting, 2013). In previous analyses of USV spectrotemporal
features in mouse models of intellectual and developmental
disorder risk factors and early drug exposure models, we and
others have demonstrated the vulnerability of these features
to genetic and early environmental insults (Dougherty et al.,
2013; Maloney et al., 2018a,b; Kopp et al., 2019). We examined
call features including call duration, pitch range and mean,
peak power, and fraction of calls with a pitch jump. Prolonged
Oxy administration narrowed the USV pitch range compared
to USVs produced by in utero Oxy pups and prolonged Veh
controls (Figure 5A). Prolonged Oxy exposure also led to a
highly significant reduction in mean pitch of USVs in prolonged
Oxy male pups compared to in utero Oxy and prolonged Veh
males (Figure 5B). Interestingly, USVs produced by prolonged
Oxy female pups did not show a significant difference in pitch
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(p = 0.000012) and relative to in utero Oxy exposure (p = 0.005). (B,C) Cumulative mean pitch (Hz) in (B) male and (C) female offspring (drug, p = 1.9953E- 7 ;
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Error bars represent standard error.

post-natal exposure on early development. However, many
infants with NAS experience decreased bonding time and
skin–skin contact with the biological mother secondary to
socioeconomic barriers and are cared for by healthcare staff
for NAS. This type of setting may result in an environmental
stressor to the neonate due to inconsistent maternal contact,
frequent alteration of caregivers, along with a higher incidence
of foster care placement following hospital discharge in neonates
with maternal history of drug use (Brundage and Levine,
2019). As a result, we rationalized a cross-foster approach
would be a feasible model for evaluating the effects of in utero
opioid exposure on developmental impact in the in utero Oxy
group.
In utero Oxy exposure decreased weight gain trajectory
following weaning from foster dams, in male offspring.
Further, in utero Oxy-exposed male and female pups

DISCUSSION
Here we present a novel model to investigate the ontogenetic
impact of in utero only versus prolonged mitigating opioid
exposure on early neurodevelopmental outcomes, while
controlling for confounding factors present in clinical
observational studies. The utilization of a biological dam
and cross-foster dam in our novel model of ontogenetic rodent
exposure was based on an attempt to parallel opioid exposure
through a method most consistent with clinical management
and observations. Active maternal bonding and breast-feeding
has been shown to decrease hospitalization length, decrease rates
of pharmacotherapy administration, and decrease NAS severity
in the NICU (Rosenthal and Baxter, 2019). The prolonged Oxy
group remained with the biological dam and was weaned off
Oxy through lactation, allowing for the assessment of continued
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feeding behaviors secondary to Oxy exposure, since the opioid
system has a strong role driving food intake homeostasis
(Valbrun and Zvonarev, 2020).
Early Oxy cessation significantly decreased weight gain
trajectory in a sex-specific manner not observed in the prolonged
Oxy exposure cohort. Interestingly, in utero Oxy exposure led
to significantly higher weight at P5 in males, though both
groups show comparable averages at P21. Female weights
following in utero Oxy exposure do not show any significant
weight differences from controls. Males exposed to Oxy in
utero showed a rapid, significant and persistent decrease in
weight gain following weaning. Since the in utero exposure
group was cross-fostered at birth to a non-drug exposed
dam, normal weight gain trajectory was potentially maintained
through adequate maternal care from the foster dam. A further
explanation could be the “two-hit” hypothesis in which early
life susceptibility, such as abstinence and withdrawal following
in utero Oxy exposure, compounded with the post-natal stress
of weaning precipitated a weight loss phenotype (Nederhof
and Schmidt, 2012; Peña et al., 2019). Perhaps, males are
more sensitive to early life stressors and may have longterm consequences from in utero opioid exposure compared
to females. Male human neonates are more at risk for
developing NAS compared to females, so long-term changes
in opioid circuitry governing feeding behaviors could explain
the abnormal weight trajectory in male mouse offspring postweaning (Charles et al., 2017). Prospective human studies
evaluating the long-term effects of in utero opioid and effects
on weight trajectory during childhood through adulthood have
not been performed to our knowledge. The altered weight
trajectory findings in both the in utero Oxy and prolonged Oxy
suggest a potential role of in utero opioid exposure on longterm impact on growth that requires further evaluation in the
human literature.
In the vehicle-treated groups, cross-fostered pups showed
decreased weight gain trajectory after weaning relative to pups
reared by a biological dam. Our observation of decreased
weight gain following weaning in Veh-exposed cross-fostered
pups may be related to potential alterations in emotionality
and stress responses secondary to confounders involved with
cross-fostering, such as early handling (Luchetti et al., 2015).
Regardless, the effect of cross-fostering on weight did not mask
our ability to identify effects of in utero Oxy exposure on
weight in males. Indeed, the effect of in utero Oxy exposure
on weight occurred at additional younger ages and with a
larger magnitude than in utero Veh exposure and persisted
when controlling for effects of litter and cross-fostered dam
status. Similarly, in females, weight reduction was observed
following prolonged Oxy exposure compared to prolonged Veh
controls, and in utero Veh exposure compared to the prolonged
Veh exposure control group. Despite the independent effect
on weight by cross-fostering, this method was valuable in
allowing us to cease Oxy exposure at birth and thus observe
effect of Oxy limited to in utero development. Furthermore,
these findings highlight the importance of including proper
cross-foster control groups in study designs for accurate
interpretation of results.

showed alterations in the spectrotemporal features of USVs.
Meanwhile, offspring with prolonged Oxy exposure until
weaning at P21 demonstrated poorer neurodevelopmental
outcomes compared to mice exposed only until birth.
Notably, continued post-natal Oxy exposure was associated
with decreased weight gain trajectory, impaired motor
reflexes, and abnormal early communication behaviors.
Both male and female offspring in prolonged Oxy
exposure groups had decreased weight gain following
weaning at P21, with delayed latency to right observed
in females. In addition, prolonged Oxy-exposed offspring
had significantly reduced USV production and alterations
in spectrotemporal features reflecting affective and early
communicative impairment.

Oxycodone Exposure Impairs Attainment
of Physical and Motor Development
Decreased fetal growth can be used as a general indicator of
harmful in utero drug exposures (Haight, 2018). The association
between birth weight and decreased infant survival is highly
robust, though the underlying biological mechanisms are not
always clearly understood (Basso et al., 2006; Yazdy et al.,
2015). We did not obtain birth weights at P0 in order
to minimize animal handling which can reduce behavioral
and hormonal reactivity to stress and confound behavioral
testing results (Luchetti et al., 2015). Initial weight assessment
occurred at P5 with no observed effect of in utero or
prolonged Oxy exposure relative to Veh controls. Overall,
human literature shows low birth weight in the setting of
maternal methadone use during pregnancy, but no evidence of
low birth weight following in utero exposure to other opioids
including codeine, tramadol, hydrocodone, or Oxy (Yazdy et al.,
2015). Thus, our findings are consistent with existing Oxy
human literature that shows no reported association between
Oxy and low birth weight in neonates (Kelly et al., 2011;
Yazdy et al., 2015).
Interestingly, female offspring exposed to continued Oxy,
relative to Veh controls, showed a significant decrease in
weight after weaning at P21, which persisted through P25,
early juvenile development in mice. Neurodevelopmental
processes occurring at these ages in the rodent occur in the
human at approximately 2–3 years and pre-pubertal juvenile
ages, respectively (Semple et al., 2013). Male weights, after
prolonged exposure, showed a significant decline on P25–
P30 as compared to Veh controls. Since these offspring were
separated from the dam partially through a period during
which they are naturally weaning from nursing (König
and Markl, 1987), it is unclear whether the acute onset of
decreased weight gain after separation from the dam at P21
is related to Oxy withdrawal symptomatology or not. It
is certainly plausible. However, human studies of prenatal
opioid exposure have described decreased adaptive behaviors
during infancy through toddlerhood (Conradt et al., 2019).
Cessation of care from the biological dam may potentially have
uncovered deficiencies in self-care of offspring. The decreased
weight gain post-weaning could also stem from maladaptive
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Prenatal opioid exposure has also been associated with delays
in attainment of motor milestones in children. A meta-analysis
by Yeoh et al. (2019) detected significant delays in motor
outcomes in children aged 0–6 years that experienced prenatal
opioid exposure. We assessed the righting reflex at P14, the
beginning of the visual critical period, and an age at which mice
should be fully ambulatory (Williams and Scott, 1954; Hooks
and Chen, 2007; Feather-Schussler and Ferguson, 2016). The
righting reflex corrects the orientation of the body from an off
axis position (Troiani et al., 2005). Proper execution of the reflex
requires a combination of visual, vestibular, and somatosensory
system inputs to make appropriate postural adjustments through
neural pathways within the brain and cerebellum. Females in
the prolonged Oxy exposure group had significantly increased
latency to right compared to Veh controls. There was no
significant difference in righting reflex latency between females
exposed to Oxy and Veh in utero. Hence, only continued postnatal Oxy exposure seems to result in delayed sensorimotor
development. Previously, increased latency to right has been
demonstrated with in utero morphine exposure in both male
and female rat pups, but rodent studies evaluating effects of
opioids on the righting reflex have been limited (Slamberová
et al., 2005). Though the exact mechanism of action is unclear,
significant evidence in the literature demonstrates selective
vulnerability of cerebellar granule neuroblasts to opioids, along
with opioids’ negative effects on neuronal somatosensory cortex
development (Seatriz and Hammer, 1993; Hauser et al., 2003).
Multiple studies have further linked opioid exposure to increased
apoptosis and decreased differentiation of Purkinje cells in
the cerebellum (Hauser et al., 2003). Additionally, perinatal
morphine treatment in rats decreased total number of neurons
in the somatosensory cortex (Seatriz and Hammer, 1993).
Thus, it is possible multiple circuits are mediating the effect.
Overall, the sex-specificity of the effect is also interesting. This
observed sex bias could be related to sex-specific dimorphic
alterations in catecholamine levels in the cerebellum as shown
in a previous study of prenatal morphine exposure (Vathy
et al., 1995). Interestingly, cross-fostering resulted in a shorter
latency to exhibit the righting reflex in males compared to
male pups reared by biological dams. This reflex is dependent
on vestibular inputs that sense head movement but lacks
cortical involvement. The righting reflex is frequently used
in studies evaluating anesthesia reversal, sepsis survival or
traumatic brain injuries (Gao and Calderon, 2020). In general,
an increased latency to right is associated with decreased
arousal or underlying neurological impairment but a decreased
latency has not been shown to correlate with any particular
pathophysiological condition or stressed anxiety state (Gao
and Calderon, 2020). Decreased latency to right is unlikely
to be linked to a behavioral or neurological impairment but
could be secondary to a non-pathological increased arousal
state due to cross-fostering in these litters. Overall, the shorter
latency seen to right in the cross-fostered group is likely
not indicative of altered development of sensorimotor reflexes.
However, future studies will be necessary to delineate the
mechanisms underlying this behavioral phenotype, and its sexspecific expression.
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Ontogenetic Oxycodone Exposure May
Delay Early Communicative Behaviors
and Alter Spectrotemporal Features of
USVs
Currently, studies exploring the effects of prenatal opioid
exposure on language development in children demonstrate
equivocal results (Conradt et al., 2019). Previous work has
identified language development impairments following in utero
exposure to methadone or heroin (Conradt et al., 2019).
However, several of these analyses did not control for important
confounders such as socioeconomic status or maternal use
of other substances. In general, large epidemiological studies
evaluating impact of prenatal opioid exposure on language
development have been difficult to perform due to various
confounding environmental variables including quality of
caregiving, parental education level, and socioeconomic factors.
Despite the advantage of limiting confounds through the use
of rodent models, and indications that communicative circuits
are conserved between rodents and humans (Arriaga et al.,
2012), there have been minimal rodent studies evaluating the
effects of prenatal opioid exposure on early communicative
behaviors to date. Isolation-induced USVs are a strongly
conserved adaptive response of young rodent pups to elicit
maternal caregiving responses (Haack et al., 2009). Our observed
collective decrease in mean USV production following prolonged
Oxy exposure, compared to in utero Oxy exposure and
Veh controls, is suggestive of impaired early communication.
Previous studies have shown evidence for neuropharmacological
modulation of USVs through alteration of mood or arousal
state (Vivian and Miczek, 1991, 1993b; Maloney et al., 2018a).
In addition to serving as an analgesic, Oxy is also a sedative
and an anxiolytic agent, which may decrease USV calling
in the prolonged Oxy exposure pups by actively suppressing
USV circuitry secondary to reduced reactivity to surrounding
environmental stressors and decreased respiratory rate (Rao
and Desai, 2002). Furthermore, the interplay between pup
communication and maternal care is complicated. In vocally
impaired pups, decreased USV production has been shown
to result in maternal neglect, because without calls the dams
cannot locate the pups outside of the nest (HernandezMiranda et al., 2017). Thus, maternal care may be reduced in
response to decreased USVs calling by prolonged Oxy-exposed
pups. Maternal care has also been reported to be attenuated
following morphine exposure during pregnancy, with a study
reporting increased time to pup retrieval, decreased nursing
and cleaning of pups, and increased maternal self-care time
(Slamberová et al., 2001). This reduced maternal care could
further disrupt neurodevelopment of the pup, and thus be a
possible indirect influence on later adult behaviors. However,
currently the literature on maternal care following Oxy exposure
is conflicting. Two recent rodent studies found no changes in
maternal behavior or maternal motivation following dam Oxy
exposure (Watters et al., 2020; Zanni et al., 2020). Notably,
in our study, in utero Oxy exposed offspring demonstrated
comparable USV means to Veh controls. Normal USV call
production in the in utero Oxy offspring at P5 suggests that,
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Oxy cessation can be appropriately modeled in rodents. If so,
testing of novel agents for treatment of withdrawal symptoms
will be possible, with the goal of limiting continued post-natal
opioid exposure given potential long-term side effects of early
post-natal opioid administration on neurodevelopment (Attarian
et al., 2014). Finally, few mouse models of in utero opioid
exposure currently exist, with the majority of the literature
utilizing rat perinatal opioid models. Thus, our model will
facilitate genetic manipulations using established cutting-edge
genetic tools available in the mouse to broaden understanding
of the mechanisms mediating consequences of early opioid
exposure on neurodevelopment.

in the prolonged exposure group, Oxy reduces USV production
by acute suppression of USV circuits. Finally, the adequate
weight trajectories before weaning in the Oxy group further
indicate appropriate dam care. Hence, we would hypothesize
that maternal care likely did not result in the behavioral
deficits observed. Still, to our knowledge, the direct impact of
Oxy exposure on maternal behaviors has not been examined.
Furthermore, there is currently scant literature considering
the effect of ongoing Oxy exposure on maternal behavior in
rodents, with even more limited studies utilizing a mouse
model. This warrants an individual study to assess reciprocity of
interactions between pup and dam. Overall, deficits in observed
USV production could be the result of a combination of
factors, including acute drug effects on circuits, influence of
dam care, and opioid-mediated effects on neural development
and communication.
Affective characteristics of USVs in rodents are generally
thought to communicate different emotional states, such as
aggression or pain. Rodent USVs are particularly interesting
as they occur only in salient situations such as exposure to
painful stimuli, maternal behavior, sexual behavior, or aggression.
As has been well-characterized in rats, affective features of
rodent USVs may be reflected by alterations in duration,
pitch, frequency, and loudness (dB) of the calls (Vivian and
Miczek, 1993a,b). In our developmental cohort, pups exposed
to prolonged Oxy demonstrated decreased mean pitch (in males
only), and narrower pitch range. Interestingly, a previous study
administered morphine to adult rats and observed decreased
USV pitch, duration, and rate (Vivian and Miczek, 1993a). The
decreased pitch and pitch range could be a result of Oxy’s
depressive effects on respiration, or of Oxy’s anxiolytic drug
properties which may dampen USV circuity. For the in utero
Oxy exposure group, we predicted increased USV production
along with increased duration, pitch, frequency, and amplitude
of USVs secondary to discomfort associated with withdrawal.
The assumption is based on the current human description
of NAS characterized by human neonates exhibiting prolonged
periods of high-pitched crying and inconsolability secondary to
withdrawal (Anbalagan and Mendez, 2020). However, human
studies do not formally characterize the spectrotemporal features
of crying in infants with NAS, so the description of a highpitched cry may be subjective in nature. We found that that
continued opioid exposure during the post-natal period in the
prolonged Oxy group resulted in less USV calls compared to
both the in utero Oxy and vehicle controls. We did not expect
the prolonged Oxy group to be undergoing withdrawal at this
time, thus we did not hypothesize an increase in call rate in this
group. A reduction in call rate is likely more consistent with an
acute dampening of the circuits mediating USV production by
the continued presence of Oxy in these pups during recordings.
Indeed, reduced call rates were observed in rat pups following
injection of µ- or δ-opioid receptor agonists (Carden et al.,
1991). Future studies are needed to evaluate the impact of early
suppression of these social communicative circuits by opioid
agonists on social behavior consequences at older ages.
Our novel Oxy administration paradigm enables future
exploration of withdrawal periods, to determine if NAS following
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